These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21451526)

  • 1. Fractalkine and its receptor, CX3CR1, promote hypertensive interstitial fibrosis in the kidney.
    Shimizu K; Furuichi K; Sakai N; Kitagawa K; Matsushima K; Mukaida N; Kaneko S; Wada T
    Hypertens Res; 2011 Jun; 34(6):747-52. PubMed ID: 21451526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractalkine receptor (CX3CR1) inhibition is protective against ischemic acute renal failure in mice.
    Oh DJ; Dursun B; He Z; Lu L; Hoke TS; Ljubanovic D; Faubel S; Edelstein CL
    Am J Physiol Renal Physiol; 2008 Jan; 294(1):F264-71. PubMed ID: 18003857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokine receptors CCR2 and CX3CR1 regulate skin fibrosis in the mouse model of cytokine-induced systemic sclerosis.
    Arai M; Ikawa Y; Chujo S; Hamaguchi Y; Ishida W; Shirasaki F; Hasegawa M; Mukaida N; Fujimoto M; Takehara K
    J Dermatol Sci; 2013 Mar; 69(3):250-8. PubMed ID: 23142052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-κB-mediated inverse regulation of fractalkine and CX3CR1 during CLP-induced sepsis.
    Raspé C; Höcherl K; Rath S; Sauvant C; Bucher M
    Cytokine; 2013 Jan; 61(1):97-103. PubMed ID: 23026294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crucial involvement of the CX3CR1-CX3CL1 axis in dextran sulfate sodium-mediated acute colitis in mice.
    Kostadinova FI; Baba T; Ishida Y; Kondo T; Popivanova BK; Mukaida N
    J Leukoc Biol; 2010 Jul; 88(1):133-43. PubMed ID: 20335311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CX3CL1-CX3CR1 Interaction Increases the Population of Ly6C(-)CX3CR1(hi) Macrophages Contributing to Unilateral Ureteral Obstruction-Induced Fibrosis.
    Peng X; Zhang J; Xiao Z; Dong Y; Du J
    J Immunol; 2015 Sep; 195(6):2797-805. PubMed ID: 26254342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS.
    Hughes PM; Botham MS; Frentzel S; Mir A; Perry VH
    Glia; 2002 Mar; 37(4):314-27. PubMed ID: 11870871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractalkine-CX3CR1-dependent recruitment and retention of human CD1c+ myeloid dendritic cells by in vitro-activated proximal tubular epithelial cells.
    Kassianos AJ; Wang X; Sampangi S; Afrin S; Wilkinson R; Healy H
    Kidney Int; 2015 Jun; 87(6):1153-63. PubMed ID: 25587706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective roles of the fractalkine/CX3CL1-CX3CR1 interactions in alkali-induced corneal neovascularization through enhanced antiangiogenic factor expression.
    Lu P; Li L; Kuno K; Wu Y; Baba T; Li YY; Zhang X; Mukaida N
    J Immunol; 2008 Mar; 180(6):4283-91. PubMed ID: 18322241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of fractalkine, CX3CR1, and vascular endothelial growth factor in human chronic renal allograft rejection.
    Cao G; Lu Y; Gao R; Xin Y; Teng D; Wang J; Li Y
    Transplant Proc; 2006 Sep; 38(7):1998-2000. PubMed ID: 16979977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential.
    D'Haese JG; Demir IE; Friess H; Ceyhan GO
    Expert Opin Ther Targets; 2010 Feb; 14(2):207-19. PubMed ID: 20055718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of fractalkine/CX3CL1 and fractalkine receptor (CX3CR1) expression in abdominal aortic aneurysm disease.
    Patel A; Jagadesham VP; Porter KE; Scott DJ; Carding SR
    Eur J Vasc Endovasc Surg; 2008 Jul; 36(1):20-7. PubMed ID: 18296082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipopolysaccharide increases monocyte binding to mesangial cells through fractalkine and its receptor.
    Park J; Song KH; Ha H
    Transplant Proc; 2012 May; 44(4):1029-31. PubMed ID: 22564617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts.
    Isse K; Harada K; Zen Y; Kamihira T; Shimoda S; Harada M; Nakanuma Y
    Hepatology; 2005 Mar; 41(3):506-16. PubMed ID: 15726664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chemokine receptor CX
    Ahadzadeh E; Rosendahl A; Czesla D; Steffens P; Prüßner L; Meyer-Schwesinger C; Wanner N; Paust HJ; Huber TB; Stahl RAK; Wiech T; Kurts C; Seniuk A; Ehmke H; Wenzel UO
    Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1526-F1535. PubMed ID: 30207169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-1RI deficiency ameliorates early experimental renal interstitial fibrosis.
    Jones LK; O'Sullivan KM; Semple T; Kuligowski MP; Fukami K; Ma FY; Nikolic-Paterson DJ; Holdsworth SR; Kitching AR
    Nephrol Dial Transplant; 2009 Oct; 24(10):3024-32. PubMed ID: 19465557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of CX3CR1/CX3CL1 axis in primary and secondary involvement of the nervous system by cancer.
    Marchesi F; Locatelli M; Solinas G; Erreni M; Allavena P; Mantovani A
    J Neuroimmunol; 2010 Jul; 224(1-2):39-44. PubMed ID: 20630606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractalkine and CX3CR1 are involved in the migration of intravenously grafted human bone marrow stromal cells toward ischemic brain lesion in rats.
    Zhu J; Zhou Z; Liu Y; Zheng J
    Brain Res; 2009 Sep; 1287():173-83. PubMed ID: 19563789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CX3CL1-CX3CR1 interaction prevents carbon tetrachloride-induced liver inflammation and fibrosis in mice.
    Aoyama T; Inokuchi S; Brenner DA; Seki E
    Hepatology; 2010 Oct; 52(4):1390-400. PubMed ID: 20683935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in Wegener's granulomatosis--possible role in vascular inflammation.
    Bjerkeli V; Damås JK; Fevang B; Holter JC; Aukrust P; Frøland SS
    Rheumatology (Oxford); 2007 Sep; 46(9):1422-7. PubMed ID: 17616549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.